Siemens Healthineers AG (WBO:SHL) Total Liabilities : €28,487 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Total Liabilities?

Siemens Healthineers AG's Total Liabilities for the quarter that ended in Dec. 2024 was €28,487 Mil.

Siemens Healthineers AG's quarterly Total Liabilities declined from Jun. 2024 (€28,344.00 Mil) to Sep. 2024 (€27,807.00 Mil) but then increased from Sep. 2024 (€27,807.00 Mil) to Dec. 2024 (€28,487.00 Mil).

Siemens Healthineers AG's annual Total Liabilities declined from Sep. 2022 (€29,204.00 Mil) to Sep. 2023 (€28,551.00 Mil) and declined from Sep. 2023 (€28,551.00 Mil) to Sep. 2024 (€27,807.00 Mil).

Siemens Healthineers AG Total Liabilities Historical Data

The historical data trend for Siemens Healthineers AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Total Liabilities Chart

Siemens Healthineers AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Total Liabilities

Get a 7-Day Free Trial

12,583.00

25,823.00

29,204.00

28,551.00

27,807.00

Siemens Healthineers AG Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															27,651.00	27,666.00	28,344.00	27,807.00	28,487.00

Siemens Healthineers AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Siemens Healthineers AG's Total Liabilities for the fiscal year that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11573	+	(513	+	2041
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	739	+	12941)
	=	27,807

Total Liabilities	=	Total Assets (A: Sep. 2024 )	-	Total Equity (A: Sep. 2024 )
	=	46055	-	18248
	=	27,807

Siemens Healthineers AG's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11547	+	(517	+	2290
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	572	+	12941)
	=	28,487

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	48317	-	19830
	=	28,487

Siemens Healthineers AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Siemens Healthineers AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (WBO:SHL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SEMHF:USA SMMNY:USA 1SHL:Italy SHLd:UK 0PMJ:UK SHL:Germany SHL:Bulgaria

Address

Siemensstrasse 3, Forchheim, BY, DEU, 91301

Website

https://www.siemens-healthineers.com

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines